Abstract
Although Parkinson’s disease (PD) is traditionally viewed as a movement disorder which affects quality of life, recent literature has revealed an increased mortality, a high burden of difficult-to-manage non-motor symptoms (e.g., pain, fatigue), high caregiver distress, and a high utilization of medical services especially in the last year of life. Current medical systems have yet to adequately respond to this mounting evidence through the adoption of palliative care practices and through the provision of palliative care services to both PD patients and to affected families. This holistic, interdisciplinary approach to practice would enhance care delivery, identify and address unmet needs, and avoid interventions and hospitalizations especially in the last months of life. As we approach an era of increased life expectancy, increasing comorbidities among patients, and escalating healthcare costs, physicians must be proactive in focusing on quality of life, reducing medical interventions, and respecting patient autonomy.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance
Auyeung M, Tsoi TH, Mok V, Cheung CM, Lee CN, Li R, et al. Ten year survival and outcomes in a prospective cohort of new onset Chinese Parkinson’s disease patients. JNNP. 2012;83:607–11.
Willis AW, Schootman M, Kung N, Evanoff BA, Perlmutter JS, Racette BA. Predictors of survival in Parkinson disease. Arch Neurol. 2012;69(5):601–7.
Duarte J, Garcia Olmos LM, Mendoza A, Clveria LE. The natural history of Parkinson’s disease in the province of Segovia: mortality in a longitudinal study (20 year follow-up). Acta Neurol Scand. 2013;127:295–300.
Hely MA, Reid WGJ, Adena MA, Halliday GM, Morris JGL. The Sydney multicenter study of Parkinson’s disease: the inevitability of dementia at 20 years. Mov Disord. 2008;23:837–44.
Sleeman KE, Ho YK, Verne J, Glickman M, Silber E, Gao W, et al. Place of death and its relation with underlying cause of death in Parkinson’s disease, motor neurone disease and multiple sclerosis: a population based study. Palliat Med. 2013;27:840–6. Comparison of place of death and cause for PD with other neurologic illnesses.
Snell K, Pennington S, Lee M, Walker R. The place of death in Parkinson’s disease. Age Aging 2009;38:617-9.
Walker RW, Churm D, Dewhurst F, Samuel M, Ramsell A, Lawrie C, et al. Palliative care in people with idiopathic Parkinson’s disease who die in hospital. BMJ Support Palliat Care. 2014;4:64–7.
Alves G, Wentzel-Larsen T, Aarsland D, Larsen JP. Progression of motor impairment and disability in Parkinson disease. A population-based study. Neurology. 2005;65:1436–41.
Kempster PA, Williams DR, Selikhova M, Holton J, Revesz T, Lees AJ. Patterns of levodopa response in Parkinson’s disease: a clinic-pathological study. Brain. 2007;130:2123–8.
Chung S, Bohnen NI, Albin RL, Frey KA, Muller ML, Chervin RD. Insomnia and sleepiness in Parkinson disease: associations with symptoms and comorbidities. J Clin Sleep Med. 2013;15(9):1131–7.
Carneiro D, de Sales CM, Rodrigues Belo L, et al. Quality of life related to swallowing in Parkinson’s disease. Dysphagia. 2014. doi:10.1007/s00455-014-9548-3.
Hely MA, Morris JGL, Reid WGH, Trafficante R. Sydney multicenter study of Parkinson’s disease: non-L-dopa-responsive problems dominate at 15 years. Mov Disord. 2005;20:190–9.
Gerlach OHH, Winogrodzka AN, Weber WEJ. Clinical problems in the hospitalized Parkinson’s disease patient: systematic review. Mov Disord. 2011;26:197–208. A meta-analysis of the complications for PD patients in hospital and admission diagnosis.
Hassan A, Wu SS, Schmidt P, Malaty IA, Dai YF, Miyasaki JM, et al. What are the issues facing Parkinson’s disease patients at ten years of disease and beyond? Data from the NPF-QII study. Parkinsonism Relat Disord. 2012;18 Suppl 3:S10–4. Based on a large cohort of PD patients followed over many years.
Hassan A, Wu SS, Schmidt P, Dai Y, Simuni T, Giladi N, et al. High rates and the risk factors for emergency room visits and hospitalization in Parkinson’s disease. Parkinsonism Relat Disord. 2013;19:949–54.
Lubomski M, Rushworth RL, Tisch S. Hospitalisation and comorbidities in Parkinson’s disease: a large Australian retrospective study. J Neurol Neurosurg Psychiatry. 2014. doi:10.1136/jnnp-2014-307822.
Hasson F, Kernohan WG, Mclaughlin M, Waldron M, McLaughlin D, Chambers H, et al. An exploration into the palliative and end-of-life experiences of carers of people with Parkinson’s disease. Palliat Med. 2010;24:731–6.
McLaughlin D, Hasson F, Kernohan WG, Waldron M, McLaughlin M, Cochrane B, et al. Living and coping with Parkinson’s disease: perceptions of informal carers. Palliat Med. 2011;25:177–82.
Giles S, Miyasaki J. Palliative stage Parkinson’s disease: patient and family experiences of health-care services. Palliat Med. 2009;23:120–5.
Goy ER, Carter JH, Ganzini L. Parkinson disease at the end of life: caregiver perspectives. Neurology. 2007;69:611–2.
Hudson PL, Toye C, Kirstjanson LJ. Would people with Parkinson’s disease benefit from palliative care. Palliat Med. 2006;20:87–94.
Miyasaki JM, Long J, Mancini D, et al. Palliative care for advanced Parkinson disease: an interdisciplinary clinic and new scale, the ESAS-PD. Parkinsonism Relat Disord. 2012;18 suppl 3:S6–9. The first study of burden in end-stage PD and the effects of palliative care on burden and caregiver burden.
Boersma I, Miyasaki J, Kurner J, Kluger B. Palliative care and neurology. Time for a paradigm shift. Neurology. 2014;83:561–7.
The Palliative Performance Scale Version 2. Last accessed September 22, 2014 https://www.cancercare.on.ca/common/pages/UserFile.aspx?fileId=13380.
Lewis LF. Caregivers’ experiences seeking hospice care for loved ones with dementia. Qual Health Res. 2014. doi:10.1177/1049732314545888.
Centers for Medicare and Medicaid Services Home Hospice data. Last accessed September 22, 2014 http://www.cms.gov/Medicare/Medicare-fee-for-service-payment/hospice/index.html Documentation of the change in cause of death in hospice.
Horowitz R, Gramling R, Quill T. Palliative care education in US medical schools. Med Educ. 2014;48:59–65. Documentation of time spent in palliative care education and students’ discomfort with the subject.
Oneschuk D, Moloughney B, Jones-McLean E, Challis A. The status of undergraduate palliative medicine education in Canada: a 2001 survey. J Palliat Care. 2004;20:32–7.
Eyigor S. Fifth-year medical students’ knowledge of palliative care and their views on the subject. J Palliat Med. 2013;16:941–6.
Peters M, Jenkinson C, Doll H, Playford ED, Fitzpatrick R. Carer quality of life and experiences of health services: a cross-sectional survey across three neurological conditions. Health Qual Life Outcomes. 2013;11:103–11.
Abernethy AP, Currow DC, Fazekas BS, Luszcz MA, Wheeler JL, Kuchibhatla M. Specialized palliative care services are associated with improved short- and long-term caregiver outcomes. Support Care Cancer. 2008;16:585–97.
Wye L, Lasseter G, Percival J, Duncan L, Simmonds B, Purdy S. What works in “real life” to facilitate home deaths and fewer hospital admissions for those at end of life? Results from a realist evaluation of new palliative care services in two English counties. BMC Palliat Care. 2014;13:37. doi:10.1186/1472-684x-13-37. Important work demonstrating that caregiver attitudes affect emergency room utilization for patients in palliative care. Healthcare professions need to include family members in discussion at the end-of-life and engage them as members of the care “team”.
Compliance with Ethics Guidelines
Conflict of Interest
Janis M. Miyasaki has received a fellowship support grant from the American Brain Foundation and is proposing initiation of a palliative care program in neurologic illness to Alberta Health Services.
Benzi Kluger has received grants from the NIH, VAMC, Michael J. Fox Foundation, and the Colorado Clinical Translational Sciences Institute. Dr. Kluger has also received honoraria payments from the Davis Phinney Foundation and paid travel accommodations from the Parkinson’s Association of the Rockies.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Author information
Authors and Affiliations
Corresponding author
Additional information
This article is part of the Topical Collection on Movement Disorders
Rights and permissions
About this article
Cite this article
Miyasaki, J.M., Kluger, B. Palliative Care for Parkinson’s Disease: Has the Time Come?. Curr Neurol Neurosci Rep 15, 26 (2015). https://doi.org/10.1007/s11910-015-0542-4
Published:
DOI: https://doi.org/10.1007/s11910-015-0542-4